-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Thrombocytopenia Due to Platelet Activation Syndromes: HIT and Beyond

Program: General Sessions
Session: Ham-Wasserman Lecture
Saturday, December 9, 2023, 12:30 PM-1:30 PM

Andreas Greinacher, MD

Transfusion Medicine, University Medicine Greifswald, University of Greifswald, Greifswald, Germany

Disclosures: Greinacher: Aspen: Consultancy, Honoraria; Bayer Heakth Care: Consultancy, Honoraria; MacoPharma: Consultancy, Research Funding; Chromatec: Honoraria; Werfen: Consultancy, Honoraria, Other: The Greifswald University holds a patent which is also used by Werfen; Gesellschaft Thrombose Hämostaseforschung GTH: Honoraria; Deutsche Forschungsgemeinschaft, DFG: Research Funding.

OffLabel Disclosure: DOACs and intravenous immunoglobulins for PF4 antibody mediated disorders. These indications are not labelled in the package insert.

See more of: Ham-Wasserman Lecture
See more of: General Sessions